132 related articles for article (PubMed ID: 20237872)
1. Normoglycemic plasma glucose levels affect F-18 FDG uptake in the brain.
Claeys J; Mertens K; D'Asseler Y; Goethals I
Ann Nucl Med; 2010 Jul; 24(6):501-5. PubMed ID: 20237872
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Effect of Various Blood Glucose Levels on
Sarikaya I; Sarikaya A; Sharma P
J Nucl Med Technol; 2019 Dec; 47(4):313-318. PubMed ID: 31182660
[TBL] [Abstract][Full Text] [Related]
3. Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET.
Boktor RR; Walker G; Stacey R; Gledhill S; Pitman AG
J Nucl Med; 2013 May; 54(5):677-82. PubMed ID: 23512357
[TBL] [Abstract][Full Text] [Related]
4. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
Paquet N; Albert A; Foidart J; Hustinx R
J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
[TBL] [Abstract][Full Text] [Related]
5. Effect of hyperglycemia on brain and liver
Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
[TBL] [Abstract][Full Text] [Related]
6. Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study.
Kubota K; Watanabe H; Murata Y; Yukihiro M; Ito K; Morooka M; Minamimoto R; Hori A; Shibuya H
Nucl Med Biol; 2011 Apr; 38(3):347-51. PubMed ID: 21492783
[TBL] [Abstract][Full Text] [Related]
7. Decreased brain FDG uptake in patients with extensive non-Hodgkin's lymphoma lesions.
Hanaoka K; Hosono M; Shimono T; Usami K; Komeya Y; Tsuchiya N; Yamazoe Y; Ishii K; Tatsumi Y; Sumita M
Ann Nucl Med; 2010 Dec; 24(10):707-11. PubMed ID: 20824395
[TBL] [Abstract][Full Text] [Related]
8. Cerebral glucose metabolism on positron emission tomography of children.
Shan ZY; Leiker AJ; Onar-Thomas A; Li Y; Feng T; Reddick WE; Reutens DC; Shulkin BL
Hum Brain Mapp; 2014 May; 35(5):2297-309. PubMed ID: 23897639
[TBL] [Abstract][Full Text] [Related]
9. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
[TBL] [Abstract][Full Text] [Related]
10. Influence of subcutaneous administration of rapid-acting insulin in the quality of (18)F-FDG PET/CT studies.
Garcia JR; Sanchis A; Juan J; Tomas J; Domenech A; Soler M; Moragas M; Riera E
Nucl Med Commun; 2014 May; 35(5):459-65. PubMed ID: 24535382
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of an SUV normalization to 1 hour after the 18F-FDG injection.
Laffon E; Vialard J; Allard M; Ducassou D
C R Biol; 2006 Jul; 329(7):520-6. PubMed ID: 16797458
[TBL] [Abstract][Full Text] [Related]
12. Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
Nozawa A; Rivandi AH; Kanematsu M; Hoshi H; Piccioni D; Kesari S; Hoh CK
Nucl Med Commun; 2015 Jun; 36(6):573-81. PubMed ID: 25714806
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers.
Ishibashi K; Onishi A; Fujiwara Y; Ishiwata K; Ishii K
J Nucl Med; 2015 Feb; 56(2):229-33. PubMed ID: 25572094
[TBL] [Abstract][Full Text] [Related]
14. Comparison of image quality between step-and-shoot and continuous bed motion techniques in whole-body
Yamashita S; Yamamoto H; Nakaichi T; Yoneyama T; Yokoyama K
Ann Nucl Med; 2017 Nov; 31(9):686-695. PubMed ID: 28815414
[TBL] [Abstract][Full Text] [Related]
15. Test-Retest Stability of Cerebral 2-Deoxy-2-[
Sijbesma JWA; van Waarde A; Vállez García D; Boersma HH; Slart RHJA; Dierckx RAJO; Doorduin J
Mol Imaging Biol; 2019 Apr; 21(2):240-248. PubMed ID: 29987619
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
Abele JT; Fung CI
Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
[TBL] [Abstract][Full Text] [Related]
17. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
Roelcke U; Blasberg RG; von Ammon K; Hofer S; Vontobel P; Maguire RP; Radü EW; Herrmann R; Leenders KL
J Nucl Med; 1998 May; 39(5):879-84. PubMed ID: 9591593
[TBL] [Abstract][Full Text] [Related]
19. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
Doot RK; Dunnwald LK; Schubert EK; Muzi M; Peterson LM; Kinahan PE; Kurland BF; Mankoff DA
J Nucl Med; 2007 Jun; 48(6):920-5. PubMed ID: 17504870
[TBL] [Abstract][Full Text] [Related]
20. Normal FDG distribution patterns in the head and neck: PET/CT evaluation.
Nakamoto Y; Tatsumi M; Hammoud D; Cohade C; Osman MM; Wahl RL
Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
